-5%
Erythropoietin therapy, also known as EPO therapy, is a type of medical treatment that uses a man-made form of erythropoietin (EPO) to increase red blood cell production and treat anemia.
Recombinant Erythropoietin (rEPO):
- Description: rEPO is produced from genetically engineered cells and is identical to the natural form of EPO present in the body.
- Characteristics: It mirrors the structure and function of endogenous EPO.
- Usage: Widely used in medical treatments to increase red blood cell production.
Darbepoetin Alfa (DA):
- Description: Similar to rEPO, but has been modified to have an extended half-life in the body.
- Characteristics: Offers prolonged duration of action compared to rEPO.
- Usage: Employed in situations where sustained EPO activity is required.
Erythropoietin Therapy (EPO Therapy):
EPO therapy utilizes synthetic forms of erythropoietin to boost red blood cell production, treating anemia.
- Primarily prescribed for patients with kidney failure, chronic kidney disease, or anemia resulting from cancer treatments, surgery, significant blood loss, or genetic disorders.
- Before initiating EPO therapy, your doctor will likely conduct various tests including red blood cell count, hemoglobin levels, and comprehensive blood analyses.
- Your doctor will inquire about your current medications and supplements to determine appropriate dosage adjustments.
- Potential risks associated with EPO therapy include hypertension, cardiovascular events (stroke, heart attack), fluid retention, bone pain/weakness, and increased susceptibility to certain cancers, especially with prolonged high-dose usage.
EPO therapy should only be administered under the supervision of a healthcare professional, and patients should be monitored closely for adverse effects.